Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Data were presented from the phase IIa trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of the American Association for the Study of Liver Diseases in Boston, USA. Full Article at Street Insider